Skip to search formSkip to main contentSkip to account menu

Locacorten-Vioform

Known as: Locorten-Vioform, locacorten vioform 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The goal of this systematic review was to compare the efficacy and ototoxicity of Locacorten‐Vioform (Paladin Labs Inc., Montreal… 
Highly Cited
1983
Highly Cited
1983
Ten antiprotozoal drugs were tested in vitro against four axenic strains of the intestinal parasite Blastocystis hominis… 
Highly Cited
1981
Highly Cited
1981
10 cases of secondary dissemination of allergic contact dermatitis in the form of erythema multiforme-like or purpura and… 
1980
1980
Ten patients with positive patch test reactions to clioquinot were retested in 1979 after an average interval of 6 years. On… 
1979
1979
The percutaneous absorption of clioquinol from three different preparations for skin treatment (Vioform cream, Locacorten-Vioform… 
Highly Cited
1975
Highly Cited
1975
Thirty‐one proprietary corticosteroid ointments were evaluated for vasoconstriction using an occluded blanching test. The results… 
1975
1975
In a double-blind study involving 430 patients, Locacorten (0.02%)-Vioform (3%) cream was found to be highly effective in the… 
Highly Cited
1974
Highly Cited
1974
Thirty proprietary corticosteroid creams and gels were evaluated for vasoconstriction using an occluded blanching test. The… 
1949
1949